目前对IgA脏病治疗的理解和新见解
Yuemiao Zhang1,2,3,4,5, Hong Zhang1,2,3,4,5
1Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Nephrology (Carlton, Vic.)
|July 3, 2024
概括
IgA脏病 (IgAN) 是一种常见的脏疾病. 新的向疗法正在出现,将治疗从免疫抑制转向基于机制的方法,以获得更好的患者结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在全球范围内,IgA神经病变 (IgAN) 是最常见的原发性血球蛋白质神经炎.
- 接受Igan治疗的患者面临着进展到末期脏疾病的高终身风险.
- 了解Igan的发病因子对于开发向疗法至关重要.
研究的目的:
- 根据2021年KDIGO指南,审查目前的Igan治疗策略.
- 使用"多重命中假说"更新对IGAN病变的洞察力.
- 确定IgA1生产和补充剂激活中的潜在治疗点.
主要方法:
- 目前治疗指南的文献综述 (KDIGO 2021).
- 对IgAN病原和"多重命中假说"的最新研究进行分析.
- 针对新型Igan疗法的大型随机对照试验 (RCT) 发现的总结.
主要成果:
- 尼菲康和斯帕森坦已获得Igan治疗的批准.
- 德利塔西塞普是用于IGAN的非标签药物.
- 新型疗法针对的是上游IgA1生产和下游补充激活.
结论:
- 新兴的Igan治疗方法代表了向向治疗的范式转变.
- 未来的管理可能会从广泛的免疫抑制转向基于机制的干预.
- 了解致病机制是推动Igan治疗的关键.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
125
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
125
Open Angle Glaucoma: Treatment
427
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
427
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
Antihypertensive Drugs: Direct Renin Inhibitors
546
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
546
Drugs for Treatment of Ulcerative Colitis in IBD
134
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
134


